Jesper van Breeschoten

Research output

Research output per year 2021 2021 2022 2023

• 12 Article
• 2 Comment/Letter to the editor
• 2 Letter

Research output per year

Research output per year

Search results

• 2023

  Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry

  van Breeschoten, J., van den Eertwegh, A. J. M., Hilarius, D. L., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Manevski, D., Suijkerbuijk, K. P. M., Wouters, M. W. J. M. & de Wreede, L. C., 1 Mar 2023, In: European Journal of Cancer. 182, p. 132-143 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands

  van Zeijl, M. C. T., van Breeschoten, J., de Wreede, L. C., Wouters, M. W. J. M., Hilarius, D. L., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Suijkerbuijk, K. P. M., Haanen, J. B. A. G. & van den Eertwegh, A. J. M., 1 Jun 2023, In: Journal of Immunotherapy. 46, 5, p. 197-204 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review
• 2022

  Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 124, 7, (1222-1230), 10.1038/s41416-020-01229-1)

  van Breeschoten, J., Wouters, M. W. J. M., Hilarius, D. L., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J-W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Blokx, W. A. M., Tije, B-J. J. T., Veldt, A. A. M. V. D., Vreugdenhil, A., Boers-Sonderen, M. J. & van den Eertwegh, A. J. M., 18 May 2022, In: British Journal of Cancer. 126, 9, p. 1362 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study

  van Breeschoten, J., Ismail, R. K., Wouters, M. W. J. M., Hilarius, D. L., de Wreede, L. C., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Suijkerbuijk, K. P. M. & van den Eertwegh, A. J. M., 1 Oct 2022, In: JCO oncology practice. 18, 10, p. e1611-e1620

  Research output: Contribution to journal › Article › Academic › peer-review

• Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

  Ismail, R. K., van Breeschoten, J., van der Flier, S., van Loosen, C., Pasmooij, A. M. G., van Dartel, M., van den Eertwegh, A., de Boer, A., Wouters, M. & Hilarius, D., 1 Jun 2022, In: Journal of Medical Internet Research. 24, 6, e33446.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

  Ismail, R. K., van Breeschoten, J., Wouters, M. W. J. M., van Dartel, M., van der Flier, S., Reyners, A. K. L., de Graeff, P., Pasmooij, A. M. G., de Boer, A., Broekman, K. E. & Hilarius, D. L., 1 Apr 2022, In: Breast. 62, p. 180 1 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study

  van Not, O. J., de Meza, M. M., van den Eertwegh, A. J. M., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., van Breeschoten, J., de Groot, J-W. B., Hospers, G. A. P., Ismail, R. K., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A. M., van der Veldt, A. A. M., Vreugdenhil, G., Bonenkamp, H. J., Boers-Sonderen, M. J., Blokx, W. A. M., & 2 othersWouters, M. W. J. M. & Suijkerbuijk, K. P. M., 1 May 2022, In: European Journal of Cancer. 167, p. 70-80 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• The unfavorable effects of COVID-19 on Dutch advanced melanoma care

  van Not, O. J., van Breeschoten, J., van den Eertwegh, A. J. M., Hilarius, D. L., de Meza, M. M., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Ismail, R. K., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense-den Boer, M. A. M., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Blokx, W. A. M., & 2 othersSuijkerbuijk, K. P. M. & Wouters, M. W. J. M., 1 Mar 2022, In: International Journal of Cancer. 150, 5, p. 816-824 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2021

  Adjuvant treatment for melanoma in clinical practice – Trial versus reality

  de Meza, M. M., Ismail, R. K., Rauwerdink, D., van Not, O. J., van Breeschoten, J., Blokx, W. A. M., de Boer, A., van Dartel, M., Hilarius, D. L., Ellebaek, E., Bonenkamp, H. J., Blank, C. U., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., de Groot, J. W. B., Haanen, J. B., Hospers, G. A. P., Kapiteijn, E. W., & 8 othersPiersma, D., van Rijn, R. S., van der Veldt, A. A. M., Vreugdenhil, A., Westgeest, H. M., van den Eertwegh, A. J. M., Suijkerbuijk, K. P. M. & Wouters, M. W. J. M., Nov 2021, In: European Journal of Cancer. 158, p. 234-245 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• An invisible group of COVID-19 victims; impact on Dutch lung cancer care

  van Breeschoten, J., Ismail, R., Smit, H., Schuurbiers, O. & Schramel, F., Sept 2021, In: Lung Cancer. 159, p. 177-178 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 10.1038/s41416-020-01229-1): First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF^V600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 124, 7, (1222-1230), 10.1038/s41416-020-01229-1)

  van Breeschoten, J., Wouters, M. W. J. M., Hilarius, D. L., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J-W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Blokx, W. A. M., ten Tije, B-J. J., van der Veldt, A. A. M., Vreugdenhil, A., Boers-Sonderen, M. J. & van den Eertwegh, A. J. M., 11 May 2021, In: British Journal of Cancer. 124, 10, p. 1746 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis

  van Breeschoten, J., Wouters, M. W. J. M., Hilarius, D. L., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J-W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Blokx, W. A. M., Tije, B-J. J. T., Veldt, A. A. M. V. D., Vreugdenhil, A., Boers-Sonderen, M. J. & van den Eertwegh, A. J. M., 30 Mar 2021, In: British Journal of Cancer. 124, 7, p. 1222-1230 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients: Nationwide quality assurance in the netherlands

  van Breeschoten, J., van den Eertwegh, A. J. M., de Wreede, L. C., Hilarius, D. L., van Zwet, E. W., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Stevense‐den Boer, M. A. M., van der Veldt, A. A. M., Vreugdenhil, G., Boers‐sonderen, M. J., Suijkerbuijk, K. P. M. & Wouters, M. W. J. M., 2 Oct 2021, In: Cancers. 13, 20, 5077.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Nationwide Outcomes of Advanced Melanoma According to BRAFV600Status

  van Breeschoten, J., Wouters, M. W. J. M., de Wreede, L. C., Hilarius, D. H., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J-W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Blokx, W. A. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Boers, M. J. & van den Eertwegh, A. J. M., 1 Feb 2021, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 44, 2, p. 82-89 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

  Ismail, R. K., van Breeschoten, J., Wouters, M. W. J. M., van Dartel, M., van der Flier, S., Reyners, A. K. L., de Graeff, P., Pasmooij, A. M. G., de Boer, A., Broekman, K. E. & Hilarius, D. L., 1 Dec 2021, In: Breast. 60, p. 263-271 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Trends in Use and Perceptions about Triplet Chemotherapy plus Bevacizumab for Metastatic Colorectal Cancer

  van Nassau, S. C., Bond, M. J., Scheerman, I., van Breeschoten, J., Kessels, R., Valkenburg-van Iersel, L. B., Verheul, H. M., Buffart, T. E., Mekenkamp, L. J., Lemmens, V. E., Koopman, M. & Bol, G. M., 10 Sept 2021, In: JAMA network open. 4, 9, e2124766.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access